ArticleJournal of neuro-oncology2025
Predictors and clinical implications of surgical site infections following glioma resection: a matched case-control study.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSurgical site infections (SSIs) are uncommon but clinically significant complications following glioma resection, often disrupting postoperative recovery and delaying adjuvant therapy. These patients are particularly susceptible due to several disease- and treatment-related factors. However, data on SSI predictors, outcomes, and optimal management remain limited.
methodsWe retrospectively reviewed 733 adult primary and recurrent glioma patients who underwent surgical resection between 2009 and 2024. Thirty-six patients with SSIs were matched 1:4 to 144 controls by age and gender. Predictors were evaluated using Cox proportional hazards regression. Overall survival was assessed using Kaplan-Meier and log-rank tests.
resultsSSI incidence was 4.9%, with a median onset of 35 days. On multivariable analysis, prior radiotherapy (HR: 3.92 [1.69-9.13], p < 0.001) and postoperative CSF leak (HR: 10.33 [3.7-28.8], p = 0.006) were independently associated with increased SSI risk. No significant survival difference was observed between SSI and non-SSI groups (p = 0.21). Immediate mesh cranioplasty, performed in 6 cases, demonstrated comparable outcomes to delayed cranioplasty and autologous bone replacement, with no recurrence or increased complication rates.
conclusionPostoperative CSF leak and prior radiotherapy are independent risk factors for SSIs after glioma resection. Although SSIs did not adversely impact overall survival, timely recognition and effective management remain critical. Immediate mesh cranioplasty appears to be a safe and effective option in appropriately selected cases. Further research is warranted to establish standardized guidelines for managing infected bone flaps in this population.
Indexed as
Identifiers
41162768What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.